AstraZeneca Aktie
164,15
EUR
+5,40
EUR
+3,40
%
142,76
GBP
+4,46
GBP
+3,22
%
Diese Analysten bewerten die AstraZeneca-Aktie
| Analyst | Kursziel | Abstand Kursziel | Datum | |
|---|---|---|---|---|
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 170,00 GBP | - | 16.03.2026 | |
| Jefferies & Company Inc. | 180,00 GBP | - | 06.03.2026 | |
| Deutsche Bank AG | 115,00 GBP | - | 05.03.2026 | |
| JP Morgan Chase & Co. | 151,10 GBP | - | 02.03.2026 | |
| UBS AG | 176,00 GBP | - | 26.02.2026 | |
| Bernstein Research | 205,00 GBP | - | 13.02.2026 | |
| DZ BANK | - | - | 12.02.2026 | |
| Barclays Capital | 165,00 GBP | - | 11.02.2026 | |
| Goldman Sachs Group Inc. | 163,89 GBP | - | 28.01.2026 |
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Abbott Laboratories | 0 | 0 | 0 | - | - |
| Alexion Pharmaceuticals Inc. | 0 | 0 | 0 | - | - |
| APONTIS PHARMA | 0 | 0 | 0 | - | - |
| AstraZeneca PLC | 7 | 1 | 1 | 165,75 GBP | - |
| Bayer | 5 | 4 | 1 | 39,67 EUR | - |
| BioNTech (ADRs) | 4 | 1 | 0 | 136,40 USD | +55,96% |
| CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
| Celgene Corp. | 0 | 0 | 0 | - | - |
| CureVac | 0 | 1 | 0 | - | - |
| EVOTEC SE | 2 | 1 | 0 | 8,17 EUR | - |
| Gilead Sciences Inc. | 0 | 0 | 0 | - | - |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Merck Co. | 0 | 0 | 0 | - | - |
| Merck KGaA | 4 | 3 | 0 | 140,50 EUR | - |
| Moderna Inc | 0 | 0 | 0 | - | - |
| Novartis AG | 3 | 5 | 1 | 116,88 CHF | -2,06% |
| Novavax Inc. | 0 | 0 | 0 | - | - |
| Pfizer Inc. | 1 | 5 | 0 | 28,33 USD | +2,76% |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Roche Holding AG Inhaber-Partizipationsschein | 4 | 4 | 1 | - | - |
| Sanofi S.A. | 5 | 4 | 0 | 97,62 EUR | - |
| Shanghai Fosun Pharmaceutical (Group) Co Ltd (A) | 0 | 0 | 0 | - | - |
| Sinovac Biotech LtdShs | 0 | 0 | 0 | - | - |
| STADA | 0 | 0 | 0 | - | - |
| Teva Pharmaceutical Industries Ltd. (spons. ADRs) | 0 | 0 | 0 | - | - |
| Valneva | 0 | 0 | 0 | - | - |
| Vertex Pharmaceuticals Inc. | 0 | 0 | 0 | - | - |
| Warner Chilcott plc | 0 | 0 | 0 | - | - |